Former Vice-President of Visual Effects at 20th Century Fox to Spearhead Gener8's Expansion into Growing VFX Post-Production Market
VANCOUVER, BRITISH COLUMBIA, February 11, 2014 - Gener8 Media Corp. (CNSX: GNR) announced today that Jennifer Meislohn has joined the company as managing director of its new visual effects (VFX) division called The Feder8tion, which will specialize in composite, set extension and environment work. The Feder8tion plans to hire up to 30 new employees by the end of the summer.
Meislohn comes to The Feder8tion after nearly a decade at 20th Century Fox, where she oversaw major films such as Life of Pi, Chronicle, the Night at the Museum franchises and Titanic 3D. At The Feder8tion, Meislohn will be responsible for identifying, managing and delivering VFX post-production film work to build on the success of Gener8's existing business.
"I've seen firsthand the impact that Gener8 has had on Hollywood's 3D conversion industry," said Meislohn. "From a groundbreaking process and technology to a growing list of major studio clients and films, Gener8 is fast becoming recognized as a key player for unbeatable quality and service. I'm very excited to get The Feder8tion up and running and help expand the business in a broader direction."
"Jennifer has seen the VFX industry evolve and clearly brings an interesting collaborative approach to handling the work," says Paul Becker, Executive Producer of Gener8. "I'm excited to see her build The Feder8tion and ultimately influence the VFX landscape with a new approach to business."
Rory Armes, Founder and CEO of Gener8 added: "We are delighted to add Jennifer to our growing team. Her financial and operational expertise will help us build on our success in Hollywood, and open up doors to new and lucrative opportunities."
Gener8 is a media technology company with two divisions--a studio and a technology group. Its studio is an industry leader in 3D stereo conversion services for the entertainment industry, with many high profile credits including The Amazing Spider-Man, Ghost Rider 2 and Harry Potter. The technology division provides 3D technology and cloud-based data management and analytics (Cumul8) to the entertainment industry. Gener8's head office is located in Vancouver, British Columbia and has approximately 200 employees. The executive team draws on years of experience developing graphics technology in commercial software, video games and the film industry. To learn more, visit the company website: http://www.gener8.com
ON BEHALF OF THE BOARD OF THE COMPANY
Chief Executive Officer and Director
FOR MORE INFORMATION, PLEASE CONTACT:
Vice President of Corporate Affairs
The CNSX does not accept responsibility for the adequacy or accuracy of this release.
Forward Looking Statements
Except for statements of historical fact, this news release contains certain forward-looking statements within the meaning of applicable securities law. Forward-looking statements are frequently characterized by words such as "plan", "expect", "project", "intend", "believe", "anticipate", "estimate" and other similar words, or statements that certain events or conditions "may" occur. In particular, forward-looking statements in this press release include, but are not limited to, statements with respect to: The Feder8tion and future hiring. Although the Company believes that the expectations reflected in the forward-looking statements are reasonable, there can be no assurance that such expectations will prove to be correct. Such forward-looking statements are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the statements including, without limitation, risks with respect to: general economic conditions in Canada and globally; film industry conditions; potential delays or changes in plans with respect to deployment of services or capital expenditures; possibility that government policies or laws may change; the development, implementation and execution of the Company's strategic vision; and legal and/or regulatory risks.